AWH News and Press, Aspira Women's Health Inc. From 05/08/24

AUSTIN, Texas, May 08, 2024 (GLOBE NEWSWIRE) -- Aspira Women’s Health Inc. (“Aspira” or the “Company”) (Nasdaq: AWH), a bio-analytical based women’s health company focused on the development of gynecologic disease diagnostic tools, today announced that th...

AUSTIN, Texas, May 07, 2024 (GLOBE NEWSWIRE) -- Aspira Women’s Health Inc. (“Aspira” or the “Company”) (Nasdaq: AWH), a bio-analytical based women’s health company focused on the development of gynecologic disease diagnostic tools, today announced the pub...

AUSTIN, Texas, May 02, 2024 (GLOBE NEWSWIRE) -- Aspira Women’s Health Inc. (“Aspira” or the “Company”) (Nasdaq: AWH), a bio-analytical based women’s health company focused on the development of gynecologic disease diagnostic tools, today announced the for...

AUSTIN, Texas, April 09, 2024 (GLOBE NEWSWIRE) -- Aspira Women’s Health Inc. (“Aspira” or the “Company”) (Nasdaq: AWH), a bio-analytical based women’s health company focused on the development of gynecologic disease diagnostic tools, today announced a new...

2024-04-05 17:54:29 ET More on Aspira Women’s Health Aspira Women's Health Inc. (AWH) Q4 2023 Earnings Call Transcript Aspira Women’s Health announces $5.5M registered direct offering Seeking Alpha’s Quant Rating on Aspira Women’s Health ...

2024-04-01 09:15:06 ET Cantor Fitzgerald analyst issues NEUTRAL recommendation for AWH on April 1, 2024 07:36AM ET. The previous analyst recommendation was Neutral. AWH was trading at $3.1 at issue of the analyst recommendation. Historical Analyst Recommendations L...

2024-03-28 16:10:44 ET More on Aspira Women’s Health Aspira Women's Health Inc. (AWH) Q4 2023 Earnings Call Transcript Aspira Women’s Health announces $5.5M registered direct offering Seeking Alpha’s Quant Rating on Aspira Women’s Health ...

2024-03-28 11:37:10 ET Aspira Women's Health Inc. (AWH) Q4 2023 Results Conference Call March 28, 2024 08:30 AM ET Company Participants Nicole Sandford - President and Chief Executive Officer Torsten Hombeck - Chief Financial Officer Conference Call Participant...

2023 OvaSuite revenue of $9.2 million, an increase of 15% year-over-year 2023 OvaSuite volume of 23,990 units, an increase of 12% year-over-year Cash utilization declined in both the fourth quarter and full-year 2023 to $3.5 million and $15.9 million, respectively Confer...

Swire Pacific Ltd. ADR (Class A) (SWRAY) is expected to report for Q4 2023 Troika Media Group Inc. (TRKAQ) is expected to report for quarter end 2023-12-31 American Environmental Partners Inc. (AEPT) is expected to report for quarter end 2023-12-31 Veolia Environnement S.A. ADR (VEOEY...